FutureChem Co.,Ltd (KOSDAQ:220100)
South Korea
· Delayed Price · Currency is KRW 21,950
+700 (3.29%)
Apr 1, 2025, 3:30 PM KST
FutureChem Co.,Ltd Revenue
In the year 2024, FutureChem Co.,Ltd had annual revenue of 17.29B KRW with 23.81% growth. FutureChem Co.,Ltd had revenue of 6.24B in the quarter ending December 31, 2024, with 33.34% growth.
Revenue
17.29B
Revenue Growth
+23.81%
P/S Ratio
28.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
485.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.29B | 3.33B | 23.81% |
| Dec 31, 2023 | 13.97B | 1.39B | 11.09% |
| Dec 31, 2022 | 12.57B | 755.26M | 6.39% |
| Dec 31, 2021 | 11.82B | 805.07M | 7.31% |
| Dec 31, 2020 | 11.01B | 2.85B | 34.86% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |